A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

Autor: Rao, V. Koneti, Šedivá, Anna, Dalm, Virgil A.S.H., Plebani, Alessandro, Schuetz, Catharina, Shcherbina, Anna, Trizzino, Antonino, Zharankova, Yulia, Orpia, Alanvin, Kulm, Elaine, Webster, Sharon, Körholz, Julia, Lougaris, Vassilios, Rodina, Yulia, Conlon, Niall, Coulter, Tanya, Bradt, Jason, Relan, Anurag, Uzel, Gulbu
Zdroj: In Clinical Immunology January 2025 270
Databáze: ScienceDirect
Externí odkaz: